Vistagen (NASDAQ:VTGN) Shares Fall Under $1 After Depression Drug Flunks Midstage Trial - Benzinga

Submitted by Anonymous (not verified) on Thu, 05/02/2019 - 16:13

Vistagen (NASDAQ:VTGN) Shares Fall Under $1 After Depression Drug Flunks Midstage Trial  BenzingaVistagen Therapeutics Inc (NASDAQ: VTGN) shares were nearly cut in half Thursday following adverse results from a Phase 2 study evaluating its ...